Gene protects tubby mouse strain from hearing loss

August 30, 1999

BAR HARBOR -- Researchers at The Jackson Laboratory have found a chromosomal region that interacts with the tub mutation to prevent normally occurring deafness in the tubby mouse model. Identification of the protective gene could help define shared molecular pathways underlying the multiple defects in tubby, including maturity-onset obesity, insulin resistance, and blindness.

The region, or locus, is known as moth1 (modifier of tubby hearing 1) and was traced to mouse Chromosome 2 by Drs. Akihiro Ikeda and Qing Yin Zheng in the laboratory of Drs. Patsy M. Nishina and Jürgen K. Naggert with colleagues from The Jackson Laboratory. The research appears as the cover article in the September 1999 issue of the journal Human Molecular Genetics.

The tubby mouse was characterized at the Laboratory in 1990 by Drs. Douglas Coleman and Eva Eicher as an autosomal recessive mutation in C57BL/6J ("B6") mice, one of a growing number of single-gene obesity models that includes ob (obese), db (diabetes), and cpefat. Tub was cloned in 1996 by the Nishina/Naggert group at The Jackson Laboratory and identified as a novel gene on chromosome 7.

Dr. Nishina and her colleagues have found that the tub mutation is a member of a novel family of genes that is widely distributed among species, from humans to maize. They have characterized TUB, the human homolog of tub, and family members called Tubby-Like Proteins: TULP1, TULP2, and TULP3. These mutated genes cause sensory defects in mice similar to retinitis pigmentosa and cone-rod dystrophy in humans.

Tubby mice develop hearing problems at three weeks of age, experiencing cochlear degeneration due to progressive loss of hair cells and neurons. Normal hearing results when sound waves cause the tiny hairs to oscillate, with the movement transmitted as electrical impulses through the hair cells to the brain. Hearing ability in mice is measured with a technique known as auditory brainstem response (ABR).

In their experiment, the Jackson Lab researchers crossbred C57BL/6J mice homozygous for the tub mutation with three other inbred mouse strains and used Quantitative Trait Loci (QTL) analysis to map genetic regions correlated with ABR thresholds in offspring. The results showed that all three strains carried an allele at the moth1 locus which acted to protect tub mice from hearing loss.

The researchers speculate that moth1 may be directly involved in the hearing impairment "cascade" induced by the tub mutation, which is known to induce cell death in sensory neurons. Because a single moth1 allele from the genetically unrelated strains is able to protect C57BL/6J-tub/tub mice against hearing loss, it is likely that B6 carries a recessive mutation at the moth1 locus which is necessary to mediate the effects of the tub mutation on hearing.

"Understanding 'natural' gene interactions that can delay or suppress hearing loss may provide a blueprint for creating therapeutics," says Dr. Nishina, a Staff Scientist at The Jackson Laboratory.

Moth1 maps to the region of mouse Chromosome 2 which is homologous to the region on human chromosome 15 containing a gene for Bardet-Biedl syndrome in humans. The obesity, insulin-resistance, and sensory deficits in tubby mice are similar to conditions observed in such rare genetic human diseases as Bardet-Biedl, Alström, and Prader-Willi syndromes. Further research could elucidate the common mechanisms thought to underlie these complex inherited diseases.

The research published in Human Molecular Genetics was supported by grants from the Foundation for Fighting Blindness and from AXYS Pharmaceuticals, Inc., as well as an institutional grant from the National Cancer Institute. Co-authors of the paper include Phillip Rosentiel, Terry Maddatu, Aamir Zuberi, Derry Roopenian, and Kenneth Johnson, all of The Jackson Laboratory, and Michael North of AXYS Pharmaceuticals.
-end-


Jackson Laboratory

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.